Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
These Stocks Are Moving the Most Today: Roivant Sciences, Textainer, Okta, Microsoft, Alphabet
2023-10-23 16:50
Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
You Might Like...
Nvidia Stock Is Falling. Here’s Why It Just Can’t Break the $500 Level.
Can You Play Starfield Offline?
It took 54 years, but this man just got his bachelor's degree
How to Get Blue Onions in Pikmin 4
Yamaha YH-WL500 Review
Google added a few nifty features to Password Manager
Streamer Ludwig Ahgren mocks Minecraft YouTuber Dream for his 'anti-face reveal' video, fans say 'Bro lost credibility'
Charlie Sheen's daughter Sami trolled for celebrating one-year OnlyFans anniversary: 'Go get a real job'